NOVAVAX, INC

Lobbying for NOVAVAX, INC

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Maryland · House · Senate · $190,000.00 expenses · posted Jul 21, 2025

Lobbying activity 1

Health Issues

Issues related to COVID-19 vaccines, federal vaccine programs, and vaccine regulatory frameworks Reauthorization of Pandemic and All-Hazards Preparedness Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.